EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 vif mRNA Production as Revealed by a Growth-Adaptive Mutation

Takaaki Koma iD, Naoya Doi, Bao Quoc Le, Tomoyuki Kondo, Mitsuki Ishizue, Chiaki Tokaji, Chizuko Tsukada, Akio Adachi iD, Masako Nomaguchi

Viruses · 2023

DOI: 10.3390/v15122424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Takaaki Koma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Graduate School of Medicine, Tokushima University, Tokushima 770-8503, Japan. Hauptthemen laut MEDLINE: HIV-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS, AMED, The Japan Agency for Medical Research and Development (AMED) Research Program on HIV/AIDS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have previously reported an HIV-1 mutant designated NL-Y226tac that expresses Vif at an ultra-low level, being replication-defective in high-APOBEC3G cells, such as H9. It carries a synonymous mutation within the splicing SA1 site relative to its parental clone. In order to determine whether a certain mutant(s) emerges during multi-infection cycles, we maintained H9 cells infected with a relatively low or high input of NL-Y226tac for extended time periods. Unexpectedly, we reproducibly identified a g5061a mutation in the SD2b site in the two independent long-term culture experiments that partially increases Vif expression and replication ability. Importantly, the adaptive mutation g5061a was demonstrated to enhance vif mRNA production by activation of the SA1 site mediated through increasing usage of a rarely used SD2b site. In the long-term culture initiated by a high virus input, we additionally found a Y226Fttc mutation at the original Y226tac site in SA1 that fully restores Vif expression and replication ability. As expected, the adaptive mutation Y226Fttc enhances vif mRNA production through increasing the splicing site usage of SA1. Our results here revealed the importance of the SD2b nucleotide sequence in producing vif mRNA involved in the HIV-1 adaptation and of mutual antagonism between Vif and APOBEC3 proteins in HIV-1 adaptation/evolution and survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1RNA, MessengerCell Linevif Gene Products, Human Immunodeficiency VirusVirus ReplicationCytidine DeaminaseMutation

Stichwörter der Autor:innen

APOBEC3HIV-1SA1SD2bVifadaptationsplicing

Substanzen

RNA, Messengervif Gene Products, Human Immunodeficiency VirusCytidine Deaminase

Autor:innen und Institutionen

  • Department of Microbiology, Graduate School of Medicine, Tokushima University, Tokushima 770-8503, Japan.
  • Faculty of Medicine, Tokushima University, Tokushima 770-8503, Japan.

ORCID-Profile: Takaaki Koma, Akio Adachi

Förderung

  • JSPS
  • AMED
  • The Japan Agency for Medical Research and Development (AMED) Research Program on HIV/AIDS

Zitieren

APA

Koma, T., Doi, N., Le, B. Q., Kondo, T., Ishizue, M., Tokaji, C., Tsukada, C., Adachi, A., & Nomaguchi, M. (2023). Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 vif mRNA Production as Revealed by a Growth-Adaptive Mutation. Viruses. https://doi.org/10.3390/v15122424

Vancouver

Koma T, Doi N, Le BQ, Kondo T, Ishizue M, Tokaji C, et al. Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 vif mRNA Production as Revealed by a Growth-Adaptive Mutation. Viruses. 2023. doi:10.3390/v15122424

BibTeX
@article{Koma2023,
  author = {Koma, Takaaki and Doi, Naoya and Le, Bao Quoc and Kondo, Tomoyuki and Ishizue, Mitsuki and Tokaji, Chiaki and Tsukada, Chizuko and Adachi, Akio and Nomaguchi, Masako},
  title = {Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 vif mRNA Production as Revealed by a Growth-Adaptive Mutation},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15122424}
}
Kostenlos starten →